Homocisteína

Abstract

Homocysteine, formed from hepatic methionine, is metabolized through the pathways of demethylation and transsulfuration. Its plasmatic and urinary values refl ect the cell synthesis. Its determination after fasting and increased infusion of methionine shows the differences of these two metabolic pathways, mainly when it is related to genetic diseases. Hyperhomocysteinemia has been associated with a higher risk of vascular thrombotic events. Several authors suggest a causal relationship between these events independently of other risk factors for vascular diseases. Decrease in plasmatic homocysteine to normal levels is followed by a signifi cant reduction on the incidence of vascular thrombotic events. The correlation between the liver and homocysteine is becoming more important because of the recent fi ndings that alterations of lipoproteins and methionine clearance are common in patients with hepatocellular and canalicular chronic liver disease. The treatment of hiperhomocysteinemia is based on the supplementation of folic acid and vitamins B6 and B12.